Cinepazet
| Cinepazet | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Overview[edit]
Cinepazet is a pharmaceutical compound used primarily for its vasodilator properties. It is often prescribed to improve blood flow and reduce symptoms associated with peripheral vascular disease.
Pharmacology[edit]
Cinepazet functions by relaxing the smooth muscles in the blood vessels, leading to their dilation. This action helps to increase blood flow and reduce blood pressure. The mechanism of action involves the inhibition of calcium channels, which are crucial for muscle contraction.
Clinical Uses[edit]
Cinepazet is indicated for the treatment of conditions such as intermittent claudication, a symptom of peripheral artery disease characterized by pain and cramping in the lower limbs due to inadequate blood flow. It may also be used in other conditions where improved blood circulation is beneficial.
Side Effects[edit]
Common side effects of Cinepazet include headache, dizziness, and nausea. In some cases, patients may experience hypotension or tachycardia. It is important for patients to be monitored for these adverse effects, especially when starting the medication.
Contraindications[edit]
Cinepazet should not be used in patients with a known hypersensitivity to the drug. Caution is advised in patients with severe cardiovascular disease or those who are taking other medications that affect blood pressure.
Administration[edit]
Cinepazet is typically administered orally in tablet form. The dosage and frequency depend on the specific condition being treated and the patient's response to the medication.
